Resuscitation beyond Advanced Trauma Life Support: damage control

Kaczynski, Jakub
March 2013
British Journal of Hospital Medicine (17508460);Mar2013, Vol. 74 Issue 3, p144
Academic Journal
The article discusses the general principles of the damage control concept in the management of the haemorrhaging patient. It mentions that damage control resuscitation and damage control surgery are important parts of management. Damage control resuscitation involves normalization of physiological parameters which increase the probability of survival of trauma patients and damage control surgery involves restoring physiology and then correcting anatomy; multidisciplinary care is crucial. INSET: KEY POINTS.


Related Articles

  • Behandlung von polytraumatisierten Patienten. Grottke, O.; Spahn, D.R.; Rossaint, R. // Anaesthesist;Jun2011, Vol. 60 Issue 6, p546 

    Despite improved strategies in the treatment of polytraumatized patients the mortality rate of severely injured patients remains high. Thus, worldwide 5 million patients die due to trauma or trauma-related complications each year. As the majority of early trauma-related deaths are attributed to...

  • Recombinant Factor VIIa for Life-Threatening Hemorrhage in Trauma Patients: Review of the Literature. Pape, Hans-Christoph; Erhardtsen, Elisabeth; Meyer, Christian; Leppäniemi, Ari Kalevi // European Journal of Trauma;Oct2006, Vol. 32 Issue 5, p439 

    The control of hemorrhage and coagulopathy is a vital component of trauma care, and failure to achieve hemostasis can contribute to mortality. Recombinant factor VIIa (rFVIIa) is a well-established therapy for bleeding episodes and surgical prophylaxis in hemophilia patients with inhibitors....

  • Prothrombin Complex Preparations: A Cautionary Note. Ratnoff, Oscar D. // Annals of Internal Medicine;Dec74, Vol. 81 Issue 6, p852 

    Editorial. Focuses on the lethal outcome of the use of prothrombin complex preparations for treatment of bleeding. Overview of clotting factor transfusion; Consequences of prothrombin complex infusion; Recommendations.

  • Recombinant activated Factor VII not as effective as previously thought.  // Hem/Onc Today;9/10/2010, Vol. 11 Issue 17, p18 

    The article discusses research study on the influence of recombinant activated Factor VII on bleeding model parameters, published in "Blood."

  • Uses and abuses of fresh frozen plasma for the treatment of bleeding. Desborough, M. J.; Stanworth, S. J.; Curry, N. S. // Clinical Medicine;Apr2013, Vol. 13 Issue 2, p200 

    The article discusses the use of uses and abuses of fresh frozen plasma (FFP) for the treatment of bleeding. The article describes the mechanism by which FFP treats coagulopathy. The role of FFP in major bleeding associated with and without trauma, disseminated intravascular coagulation, and...

  • Hydroxyethyl Starch 130/0.4. Cada, Dennis J.; Levien, Terri; Baker, Danial E. // Hospital Pharmacy;May2008, Vol. 43 Issue 5, p396 

    The article offers information on the use of hydroxyethyl starch (130/0.4). Such drug is a kind of synthetic colloid that is used for plasma volume replacement. It suggests that administration of such drug and other treatment should be immediately stopped if a hypersensitivity reaction occurs in...

  • Key Controversies in Colloid and Crystalloid Fluid Utilization. Frazee, Erin N.; Leedahl, David D.; Kashani, Kianoush B. // Hospital Pharmacy;Jun2015, Vol. 50 Issue 6, p446 

    Nearly 2 centuries have passed since the use of intravenous fluid became a foundational component of clinical practice. Despite a steady stream of published investigations on the topic, questions surrounding the choice, dose, timing, targets, and cost-effectiveness of various fluid options...

  • The Use of Recombinant Coagulation Factor VIIa (NovoSeven) in Severe Diverticular Bleeding. Guenin, Marc-Olivier; Peterli, Ralph; Kern, Beatrice; Ackermann, Christoph // Open Surgery Journal;2008, Vol. 2, p1 

    We report a 68-year-old man with sigmoid colon carcinoma who previously underwent an anterior resection. Five years later, he developed a severe diverticular bleeding which required multiple blood transfusions. He underwent an emergent low anterior colectomy with a right colostomy to protect the...

  • Evidence for Gene Transfer and Expression of Factor IX in Haemophilia B Patients Treated with an AAV Vector. Lampe, John B.; Danish, Elizabeth H. // Clinical Pediatrics;Aug2000, Vol. 39 Issue 8, p496 

    Presents a summary of a study which examined the evidence of gene-based treatment and the expression of factor IX characterized by the episodes of spontaneous bleeding into joints and life-threatening hemorrhages. Reduction in factor usage; Evidence of toxicity related to vector administration;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics